Its primary program targets multiple sclerosis (MS), but BioNxt also intends to apply the same proprietary drug delivery platform to develop a treatment for Myasthenia Gravis (MG), a rare autoimmune ...

Eli Lilly delivered a robust 4Q25 beat, with revenue up 43% YoY and strong EPS growth, driven by its GLP-1 franchise. Check out my latest analysis on LLY stock.

RANCHI: The Union Ministry of Home Affairs (MHA) on Wednesday announced an ambitious target to make India drug-free by ...

Experts explain how microplastics in everyday skincare may disrupt the skin barrier, cause irritation, and contribute to long ...

The Georgia carpet industry’s long use of PFAS, known as forever chemicals, polluted drinking water and the environment across swaths of the South.

The firm missed Wall Street Q4 revenue estimates but assured steady growth as it plans for Keytruda's patent expirations, a ...

The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and ...

Tuesday, Feb. 3, 2026 at 10 a.m. ET Chief Executive Officer — Dan Fachner Chief Financial Officer — Shawn Munsell Director, ...

A natural compound found in rice may help protect cells from age-related damage, according to Dr. Sankar Devarajan, associate ...

According to Dr. Maslow’s original formulation, there are five sets of basic needs that are related to each other in the ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

The Pax Silica initiative, in Jaishankar's formulation of India's foreign policy, requires navigating the tension between "multi-alignment" and alliance discipline.